Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Treasury Shares: 2020-2023

  • Cullinan Therapeutics' Treasury Shares was N/A to $85.6 million in Q3 2023 from the same period last year, while for Sep 2023 it was $85.6 million, marking a year-over-year change of. This contributed to the annual value of $369,000 for FY2022, which is 414506.74% up from last year.
  • Latest data reveals that Cullinan Therapeutics reported Treasury Shares of $85.6 million as of Q3 2023, which was down 0.00% from $85.6 million recorded in Q2 2023.
  • In the past 5 years, Cullinan Therapeutics' Treasury Shares ranged from a high of $85.6 million in Q2 2023 and a low of $89 during Q4 2021.
  • Over the past 3 years, Cullinan Therapeutics' median Treasury Shares value was $43.0 million (recorded in 2022), while the average stood at $42.9 million.
  • As far as peak fluctuations go, Cullinan Therapeutics' Treasury Shares plummeted by 99.98% in 2021, and later spiked by 414,506.74% in 2022.
  • Cullinan Therapeutics' Treasury Shares (Quarterly) stood at $364,000 in 2020, then plummeted by 99.98% to $89 in 2021, then soared by 414,506.74% to $369,000 in 2022, then reached $85.6 million in 2023.
  • Its Treasury Shares stands at $85.6 million for Q3 2023, versus $85.6 million for Q2 2023 and $369,000 for Q4 2022.